NCT00137852 Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer Status COMPLETED Phase PHASE2
NCT00126256 Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00111761 Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00106262 Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer Status TERMINATED Phase PHASE2
NCT00081289 Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE2
NCT00077233 FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum Status TERMINATED Phase PHASE3
NCT00072852 Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine Status COMPLETED Phase PHASE2
NCT00068692 Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer Status COMPLETED Phase PHASE3
NCT00063141 Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00061932 Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach Status COMPLETED Phase PHASE2
NCT00057837 Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00057473 A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors Status COMPLETED Phase PHASE2
NCT00053833 S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Status TERMINATED Phase PHASE2
NCT00048139 A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00048126 A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00040391 A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00037804 Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction Status COMPLETED Phase PHASE1
NCT00037180 For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy Status TERMINATED Phase PHASE2